You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 142 No. 8, August 1982 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Clinical and Subclinical Thyroid Disorders Associated With Pernicious Anemia

Observations on Abnormal Thyroid-Stimulating Hormone Levels and on a Possible Association of Blood Group O With Hyperthyroidism

Ralph Carmel, MD; Carole A. Spencer, PhD

Arch Intern Med. 1982;142(8):1465-1469.


Abstract

• Of 162 patients with pernicious anemia whom we studied, 24.1% had clinical thyroid disease; 11.7% were hypothyroid and 8.6% were hyperthyroid. When abnormal serum thyroid-stimulating hormone (TSH) levels were also considered, thyroid disorders existed in 48.3% of 143 patients. Increased or decreased TSH levels as the sole dysfunction occurred in 14.7% and 6.3% of cases, respectively, and were often associated with thyroid antibodies. The high TSH group fits the picture of subclinical hypothyroidism. The nature of the low TSH group remains to be defined. We conclude that TSH screening in patients with pernicious anemia uncovers frequent abnormalities, which are superimposed on a higher coincidence of overt thyroid disease than previously described. Interestingly, also, eight of nine hyperthyroid patients and all seven patients with low TSH levels had blood type O, contrasting significantly with hypothyroid subjects, who more often had blood type A, and with patients without thyroid disorders.

(Arch Intern Med 1982;142:1465-1469)



Author Affiliations

From the Department of Medicine, Los Angeles County-University of Southern California Medical Center and the University of Southern California School of Medicine, Los Angeles.


Footnotes

Accepted for publication May 10, 1982.

Reprint requests to Raulston 304, University of Southern California School of Medicine, 2025 Zonal Ave, Los Angeles, CA 90033 (Dr Carmel).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

How I treat cobalamin (vitamin B12) deficiency
Carmel
Blood 2008;112:2214-2221.
ABSTRACT | FULL TEXT  

Autoimmune Gastritis in Type 1 Diabetes: A Clinically Oriented Review
De Block et al.
J. Clin. Endocrinol. Metab. 2008;93:363-371.
ABSTRACT | FULL TEXT  

Different steroids co-regulate long-term expansion versus terminal differentiation in primary human erythroid progenitors
Leberbauer et al.
Blood 2005;105:85-94.
ABSTRACT | FULL TEXT  

Analysis of Human Sodium Iodide Symporter Immunoreactivity in Human Exocrine Glands
Spitzweg et al.
J. Clin. Endocrinol. Metab. 1999;84:4178-4184.
ABSTRACT | FULL TEXT  

Atrophic Body Gastritis in Patients With Autoimmune Thyroid Disease: An Underdiagnosed Association
Centanni et al.
Arch Intern Med 1999;159:1726-1730.
ABSTRACT | FULL TEXT  

Racial Differences in Serum Total Bilirubin Levels in Health and in Disease (Pernicious Anemia)
Carmel et al.
JAMA 1985;253:3416-3418.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1982 American Medical Association. All Rights Reserved.